John Waddell

John stepped down as CEO of Archangels in September 2015, having held the role for ten years. He continues to act as an adviser to Archangels and sits on the boards of three Archangels’ portfolio companies, namely MGB Biopharma, Indigo Lighthouse and NCTech. He is also on the advisory boards of Amadeus & Angels Seed Fund and Seraphim Capital and is a director of Northern 3 VCT PLC.